Connecticut legislation · 2026 General Assembly
Connecticut HB5482: AN ACT CONCERNING TWELVE-MONTH COVERAGE FOR CONTRACEPTION AND HORMONE THERAPY.
Status: Passed one chamber, May 1, 2026
What the bill says
An act concerning twelve--month coverage for contraception and hormone therapy. assembly convened.
From the introduced text:
AN ACT CONCERNING TWELVE--MONTH COVERAGE FOR CONTRACEPTION AND HORMONE THERAPY. Assembly convened: Section 1. (NEW) (Effective January 1, 2027) (a) As used in this section, "prescription hormone therapy" means all drugs approved by the United States Food and Drug Administration that are used to medically suppress, increase or replace hormones that the body is not producing at intended levels, as determined by the prescribing provider. Prescription hormone therapy does not include glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists. (b) Each individual and group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes, delivered, issued for delivery, renewed, amended or continued in this state on or after January 1, 2027, that includes coverage for prescription hormone therapy shall provide reimbursement for a twelve-month supply of covered prescription hormone therapy and any necessary supplies for administration dispensed at one time, unless the (1) insured requests a smaller supply, LCO No. 1203 1 of Raised Bill No. 5482 (2) prescribing provider instructs that the insured must receive a smaller supply, or (3) prescription hormone therapy is a controlled substance. If the prescription hormone therapy is a controlled substance, the health plan shall provide reimbursement for the maximum refills allowed under state and federal law to be obtained at …
Sponsors
- Aimee Berger-Girvalo (D, 111) · primary sponsor
- Jillian Gilchrest (D, 18)
- Julie Kushner (D, 24)
- Nicholas Gauthier (D, 38)
- Lucia Dathan (D, 142)
Latest actions
- : Senate Calendar Number 529
- : Favorable Report, Tabled for the Calendar, Senate
- : Immediate Transmittal to the Senate
- : House Passed as Amended by House Amendment Schedule A
- : House Adopted House Amendment Schedule A 5206
- : File Number 427
- : House Calendar Number 311
- : Favorable Report, Tabled for the Calendar, House
- : Reported Out of Legislative Commissioners' Office
- : Referred to Office of Legislative Research and Office of Fiscal Analysis 04/07/26 12:00 PM
Votes
- House Roll Call 184 (May 1, 2026): 129 yea, 12 nay, passed
- HS Vote Tally Sheet (Joint Favorable) (March 19, 2026): 16 yea, 7 nay, passed
Subjects: Contraceptives, Drugs, Social Services, Department of
Common questions
- What is HB5482?
- HB5482 is a bill in the Connecticut Legislature (2026 General Assembly): AN ACT CONCERNING TWELVE-MONTH COVERAGE FOR CONTRACEPTION AND HORMONE THERAPY.
- What does HB5482 do?
- In its own words: An act concerning twelve--month coverage for contraception and hormone therapy. assembly convened.
- What is the status of HB5482?
- Passed one chamber as of May 1, 2026. Latest action: Senate Calendar Number 529 (May 2, 2026).
- Who sponsored HB5482?
- Aimee Berger-Girvalo (D, 111), with 4 co-sponsors.
- Where is the official record for HB5482?
- On the Connecticut Legislature website: https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB05482&which_year=2026
Source: official Connecticut record. Tracked by Delilah, AI for legislation across all 50 states and Congress.